Coloplast AS (WBO:COLO) Debt-to-Equity : 1.26 (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Coloplast AS Debt-to-Equity?

Coloplast AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €716 Mil. Coloplast AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was €2,319 Mil. Coloplast AS's Total Stockholders Equity for the quarter that ended in Sep. 2024 was €2,406 Mil. Coloplast AS's debt to equity for the quarter that ended in Sep. 2024 was 1.26.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Coloplast AS's Debt-to-Equity or its related term are showing as below:

WBO:COLO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.24 Max: 2.26
Current: 1.26

During the past 13 years, the highest Debt-to-Equity Ratio of Coloplast AS was 2.26. The lowest was 0.02. And the median was 0.24.

WBO:COLO's Debt-to-Equity is ranked worse than
90.06% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs WBO:COLO: 1.26

Coloplast AS Debt-to-Equity Historical Data

The historical data trend for Coloplast AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Debt-to-Equity Chart

Coloplast AS Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Debt-to-Equity

Get a 7-Day Free Trial

0.24

0.34

2.26

1.13

1.26

Coloplast AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															1.13	1.43	1.51	1.48	1.26

Competitive Comparison of Coloplast AS's Debt-to-Equity

For the Medical Instruments & Supplies subindustry, Coloplast AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coloplast AS's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Debt-to-Equity falls into.

Coloplast AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Coloplast AS's Debt to Equity Ratio for the fiscal year that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(715.918	+	2319.022)	/	2406.333
	=	1.26

Coloplast AS's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(715.918	+	2319.022)	/	2406.333
	=	1.26

Coloplast AS (WBO:COLO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Coloplast AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Coloplast AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (WBO:COLO) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK COLO B:Denmark CBH:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines